EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease

Michael S Albosta, Jelani K Grant, Pam Taub, Roger S Blumenthal, Seth S Martin iD, Erin D Michos iD

Vascular Health and Risk Management · 2023-07 · Volume 19 · 421-431

DOI: 10.2147/vhrm.s338424 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vascular Health and Risk Management, 2023-07. Verfasst von Michael S Albosta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, University of Miami Miller School of Medicine/ Jackson Memorial Hospital, Miami, FL, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Atherosclerosis, Hyperlipoproteinemia Type II. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesAtherosclerosisHyperlipoproteinemia Type IIHumansProprotein Convertase 9Cholesterol, LDLRNA, Small Interfering

Stichwörter der Autor:innen

LDL-cholesterolcardiovascular disease preventioninclisiranlipids

Substanzen

ALN-PCSPCSK9 protein, humanProprotein Convertase 9Cholesterol, LDLRNA, Small Interfering

Autor:innen und Institutionen

  • Internal Medicine Department, University of Miami Miller School of Medicine/ Jackson Memorial Hospital, Miami, FL, USA.
  • Ciccarone Center for the Prevention of Cardiovascular Disease, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Division of Cardiology, University of California San Diego, San Diego, CA, USA.

ORCID-Profile: Seth S Martin, Erin D Michos

Zitieren

APA

Albosta, M. S., Grant, J. K., Taub, P., Blumenthal, R. S., Martin, S. S., & Michos, E. D. (2023). Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease. Vascular Health and Risk Management, Volume 19, 421-431. https://doi.org/10.2147/vhrm.s338424

Vancouver

Albosta MS, Grant JK, Taub P, Blumenthal RS, Martin SS, Michos ED. Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease. Vascular Health and Risk Management. 2023;Volume 19:421-431. doi:10.2147/vhrm.s338424

BibTeX
@article{Albosta2023,
  author = {Albosta, Michael S and Grant, Jelani K and Taub, Pam and Blumenthal, Roger S and Martin, Seth S and Michos, Erin D},
  title = {Inclisiran: A New Strategy for LDL-C Lowering and Prevention of Atherosclerotic Cardiovascular Disease},
  journal = {Vascular Health and Risk Management},
  year = {2023},
  volume = {Volume 19},
  pages = {421--431},
  doi = {10.2147/vhrm.s338424}
}
Kostenlos starten →